Table 4.
Adverse events.
| Control (n = 16) | Foralumab/Dexa (N = 11) | Foralumab (n = 12) | ||
|---|---|---|---|---|
| Headache | 1 | 0 | 3 | |
| Burning in the nostril | 0 | 0 | 1 | |
| Retrosternal pain | 0 | 2 | 0 | |
| Pustular Lesions and Itching in cervical area | 0 | 0 | 1 | |
| Dysuria | 1 | 0 | 0 | |
| Tachycardia (anxiety) | 0 | 1 | 0 | |
| Insomnia | 0 | 0 | 1 | |
The incidence and severity of adverse events was determined according to the National Cancer Institute Common Terminology Criteria for Adverse Events, version 5.0. Dexa= Dexamethasone.